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Abstract 
Objectives: Patients with schizophrenia often experience subtle disturbances in 
several domains of information processing – so-called basic symptoms (BS). BS are already 
present before onset of frank psychosis and can be assessed by interviews but also by the 
self-administered Frankfurt Complaint Questionnaire (FCQ). We investigated the factor 
structure, reliability and predictive validity for transition to psychosis of the FCQ, comparing 
previously proposed factor solutions containing one, two, four and ten factors. 
Methods: Confirmatory factor analysis (CFA) was used in a sample of 117 at-risk 
mental state (ARMS) and 92 first-episode psychosis (FEP) participants of the Basel FePsy 
(Early Detection of Psychosis) study. 
Results: Although all factor models fitted to the data, depending on the method used, 
the onetwo- or twofour-factor solutions with a reduced number of items performed best 
among the models that used at least half of the FCQ items, suggesting the covariance 
between FCQ items is best explained by one or twotwo to four underlying factors. No FCQ-
factor scale predicted transition to psychosis. 
Conclusion: We could confirm a onetwo- or twofour-factor structure of the FCQ in a 
sample of ARMS and FEP patients using CFA. Contrary to interview-assessed cognitive-
perceptive BS, self-assessed BS do not seem to improve prediction of psychosis. This result 
reinforces reports of poor correspondence between interview- and questionnaire-assessed 
BS. 
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Patients with schizophrenia frequently experience not only overt positive and negative 
symptoms but also various subclinical disturbances in several domains of information 
processing. These often start already several years before the onset of frank psychosis 
(Riecher-Rössler et al., 2006; Riecher-Rössler et al., 2009). Following early works of Wilhelm 
Mayer-Gross (1932), Gerd Huber (1966) first systematically described these subjective 
disturbances based on in-depth clinical interviews with patients. He coined the term “basic 
symptoms” (BS), because, based on his pioneer works on dysplastic ventricles in 
schizophrenia, he assumed them to be the most immediate psychopathological expression of 
the neurobiological changes underlying the development of psychosis (Huber and Süllwold, 
1986). BS are subjectively experienced by patients as deviations from their “normal” self and 
as a loss of control over different mental functions (Schultze-Lutter, 2009; Schultze-Lutter et 
al., 2016; Schultze-Lutter et al., 2012b). The 142 BS initially described in the interviewer 
rated Bonn Scale for the Assessment of Basic Symptoms (BSABS; Gross, 1987) can be 
present in various numbers and combinations and include self-experienced disturbances in 
thinking, attention, speech, (body) perception, motor actions, stress tolerance, drive, affective 
responses as well as central-vegetative processes. 
Developed from the BSABS as economic, age-appropriate and severity-sensitive 
interview-assessments of BS, the Schizophrenia Proneness Instrument, Adult (SPI-A; 
Schultze-Lutter et al., 2007) and Child and Youth version (SPI-CY; Schultze-Lutter et al., 
2010) are the mostly used instrument today in the clinic and in research, especially in the 
early detection of psychosis (Schultze-Lutter et al., 2012b). From interview-assessments of 
BS, two partially overlapping psychosis-risk criteria were developed, the Cognitive-
Perceptive Basic Symptoms (COPER; Klosterkötter et al., 2001) and the Cognitive 
Disturbances (COGDIS; Schultze-Lutter et al., 2007; Schultze-Lutter et al., 2006). Studies 
indicated that the combined presence of symptomatic Ultra High Risk Criteria (UHR; Yung 
and McGorry, 1996) and BS criteria almost triples the risk of developing psychosis when 
compared to the exclusive presence of either UHR (ultra-high risk) or BS criteria (Michel et 
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al., 2014; Schultze-Lutter et al., 2014; Schultze-Lutter et al., 2012a). Supported by other 
findings on a psychosis-risk enhancement by self-experienced cognitive disturbances in UHR 
samples (Nelson et al., 2012; Parnas et al., 2011; Yung et al., 2005) it was argued that 
cognitive BS in particular might capture the cognitive core dimension of psychoses that is 
hardly addressed by UHR criteria (Michel et al., 2014; Schultze-Lutter et al., 2014). All 
studies so far have been using interviewer rated scales such as the Examination of 
Anomalous Self-Experience instrument (EASE) or the BSABS. However, as the interview-
assessment of BS requires intensive training and is rather time-consuming, and as BS are 
self-experienced by nature, it is of interest if the same kind of risk-enhancement could be 
detected in UHR-samples by a self-report questionnaire. 
In close collaboration with Huber and parallel to the development of the BSABS, Lilo 
Süllwold (1991) designed a questionnaire-based assessment of BS, the German Frankfurt 
Complaint Questionnaire (FCQ; Süllwold, 1991) from example statements of the BSABS. 
The 98 dichotomous FCQ items partially overlap with each other and refer to identical 
underlying BS, e.g., a disturbance of receptive speech (BSABS-item C.1.6) is targeted by as 
much as seven different FCQ items (no. 37, 40, 69, 82, 90, 93 and 94; Michel et al., 2016a). 
The FCQ has become the main BS-questionnaire, as it was used in several different cultural 
contexts and was translated into seven languages (Michel et al., 2016b; Moritz et al., 2000b). 
Furthermore, it is still the most extensive self-report BS questionnaire used. Yet, despite its 
development based on the BSABS, the FCQ items hardly capture the same phenomena as 
interview-assessed BS (Mass et al., 1995; Michel et al., 2016a). 
Several studies of the factor structure of the FCQ yielded inconclusive results. Apart from 
the original ten theory-based factors (Süllwold, 1991), various data-based factor solutions 
including one (Loas et al., 2002; Yon et al., 2008), two (Mass et al., 1997; Mass et al., 1995) 
and four factors (Süllwold, 1991) of different total numbers of FCQ-items have been 
suggested based on different samples (Table 1). So far, the model fits of these factor 
solutions have not been formally tested and compared using confirmatory factor analysis 
(CFA). Furthermore, in all previous factor analyses, binary FCQ items were treated as 
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continuous variables, which can severely bias the resulting factor structure (Kubinger, 2003). 
Specifically, because the exploratory factor analysis (EFA) of Süllwold (1991) was performed 
on Pearson instead of the more appropriate tetrachoric correlation matrices, items were 
clustered together not only according to their content but also according to their endorsement 
probabilities. This may have led to the relatively higher number of factors by the emergence 
of “pseudo-factors” that are artifacts of item difficulty or extremeness. Thus, this study aimed 
to close both gaps in knowledge regarding the questionnaire-assessed BS: the model fit and 
reliability of the different proposed FCQ-factor solutions and the potential property of 
predicting the risk of transition to psychosis. 
First, we analyzed the psychometric properties (factor fit, internal consistency and 
homogeneity) of the FCQ and its proposed factors using confirmatory factor analysis (CFA) 
and categorical item methodology in a sample of at-risk mental state (ARMS) and first-
episode psychosis (FEP) patients. We hypothesized that the proposed factor models would 
provide a good fit to our data. Based on the so far strong evidence for a uni- or at most two-
dimensionality of the FCQ, we assumed that a one- or two-factor model would fit best. In 
addition, we expected good internal consistency but not necessarily homogeneity for all 
proposed factors. 
Second, we tested for the first time whether any of the previously proposed FCQ factors 
was predictive for a later transition to psychosis in ARMS patients. We expected that the total 
scores and in particular factors mainly consisting of the 34 cognitive and perceptive items 
most similar to the basic symptoms included in COGDIS and COPER (Table 1) would to be 
most predictive for psychosis. 
 
Table 1 about here 
 
2. Methods 
2.1. Sample and recruitment 
Study participants were recruited as part of the prospective “Früherkennung von 
Psychosen” (FePsy; English: Early detection of psychosis) project between March 2000 and 
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July 2016. A detailed description of the study design is provided in Riecher-Rössler et 
al.,(2007). In brief, patients suspected to have an ARMS for psychosis were referred to our 
specialized early detection clinic at the Psychiatric University Outpatient Department of the 
Psychiatric University Hospital Basel, Switzerland, by local psychiatrists, family doctors, or 
other hospital departments. Some also sought help with us at the advice of family members 
or through self-referral. 
To be eligible for the FePsy study participation, patients had to be at least 18 years 
old. Exclusion criteria were (1) insufficient knowledge of German, (2) indication of an IQ 
below 70, (3) psychotic symptoms within a clearly diagnosed affective psychosis or 
borderline personality disorder, (4) symptoms clearly due to organic reasons or substance 
use, and (5) antipsychotic treatment with a lifetime cumulative chlorpromazine equivalent 
dose of more than 2500mg. For the present study, patients were also excluded if they had 
not completed at least 50% of the items of the FCQ. 
Written informed consent was obtained from all participating patients. The study was 
approved by the local ethics committee (EKNZ, Ethikkommission der Nordwest- und 
Zentralschweiz) and conformed to the Declaration of Helsinki. 
 
2.2. Screening procedure 
Patients were screened with the Basel Screening Instrument for Psychosis (BSIP), 
which has good interrater reliability (Kappa = 0.67) and high psychosis-predictive validity 
(32%; Riecher-Rössler et al., 2008). Individuals were classified by the BSIP as being in an 
ARMS for psychosis, having a FEP or not being at risk for psychosis, using criteria 
corresponding to the UHR-criteria of Yung et al. (1998). 
 
2.3. Assessment of basic symptoms 
BS were assessed with the original German paper-pencil version of the FCQ 
(Süllwold, 1991), presented as part of a larger package of questionnaires at the baseline of 
the FePsy-study. The FCQ contains 98 statements describing particular complaints that are 
rated dichotomously (yes/no) indicating either presence or absence of the complaint. If 
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patients had experienced a complaint in the past but not around the time of assessment, they 
are asked to score “yes” and add the word “formerly” next to it. For the lack of detailed time 
specifications, however, these items were regarded as absent in the analyses. Earlier, good 
retest reliability and internal consistency of the FCQ were reported, with most studies 
reporting Cronbach’s alpha measures of .90 and higher in samples of schizophrenia patients 
(Süllwold, 1991; Yon et al., 2008). 
 
2.4. Follow-up and transition to psychosis 
 ARMS patients were followed-up for transition to psychosis for up to five years. 
During the first year of follow-up, patients were assessed monthly. During the second and 
third year, assessments took place every three months, thereafter patients were followed up 
annually. 
 The Brief Psychiatric Rating Scale (BPRS; Lukoff et al., 1986) items “suspiciousness”, 
“unusual thought content”, “hallucinations” and “conceptual disorganization”, which are 
included in the BSIP, were used to determine transition to psychosis in ARMS patients. 
Patients were considered to have transitioned according to criteria of Yung et al. (1998), i.e. 
when any one frank psychotic symptom (BPRS score of at least five or four for 
“hallucinations”) had persisted for more than one week. 
 
2.5. Statistical Analyses 
Confirmatory factor analyses (CFA) were used to test the fit of the six different factor 
solutions described in Table 1. The four-, two- and one-factor models were fitted using the 
weighted least square mean and variance adjusted estimator (WLSMV) as this is currently 
considered the best option for conducting a CFA with categorical data (Brown, 2015). Unlike 
other estimators for categorical data, the WLSMV produces accurate test statistics, 
parameter estimates, and standard errors even with relatively small sample sizes (Brown, 
2015). Furthermore, it provides a large variety of fit indices. We tested goodness of model fit 
using the model fit Χ2, the Comparative Fit Index (CFI), the Tucker–Lewis–Index (TLI), the 
Root Mean Square Error of Approximation (RMSEA) and the weighted root mean residual 
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(WRMR). Measures for good, adequate and poor fit respectively for all fit indices used are 
described in the footnotes below Table 3. 
Since the 10-factorial solution was too complex to be fitted using WLSMV, we 
additionally fitted all models using a Bayesian approach. A comprehensive description of 
Bayesian Structural Equation Modeling (BSEM) is provided by Muthén and Asparouhov 
(2012b). Bayesian analysis defines parameters as variables as opposed to constants, using 
the term “prior” to describe their prior distribution. Priors are typically based on hypotheses 
deducted from theory or previous analysis (Muthén and Asparouhov, 2012b). Bayesian 
analyses result in a posterior estimate, which can be considered a compromise between the 
prior and the likelihood generated using the observed data (Muthén and Asparouhov, 2012b). 
In case of weakly informative priors, this estimate is comparable to the WLSMV. Goodness 
of model fit is evaluated using the posterior predictive p-value (ppp), which represents the 
proportion of model-generated test statistics that exceeds the sample-derived test statistics. 
Thus, small values indicate poor model fit (Brown, 2015). In addition, the 95% confidence 
interval (CI) for the difference between the observed and the replicated chi-square values 
can be used to determine goodness of model fit. Good model fit is indicated if the ppp is 
close to 0.5, the lower band of the CI is negative and the difference between the observed 
and replicated chi-square value is close to the middle of the CI (Brown, 2015). 
BSEM has several advantages over traditional WLSMV analyses, including allowance 
for a more reasonable and flexible approach to model testing. Superior performance in 
smaller samples and computationally less challenging analyses are important benefits of the 
BSEM approach compared to WLSMV (Muthén and Asparouhov, 2012a). In the case of the 
current study, it proved to be especially useful to estimate a model for a complex factor 
solution with ten factors. Furthermore, compared to WLSMV, BSEM analysis allows more 
flexibility in model specification by relaxing the unrealistic assumption of strictly zero cross-
loadings and residual correlations. Therefore, it can be tested whether model fit improves by 
allowing small variance on cross-loadings, i.e. approximately zero instead of strictly zero 
(Brown, 2015). 
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We first performed Bayesian CFA on all six factor solutions (Table 1) with cross-
loadings fixed to zero comparable to the previously calculated WLSMV analysis. We used 
non-informative priors with parameters fixed to exactly zero for freely estimated residual and 
factor variances, which are the default priors of Mplus (Muthén and Muthén, 1998-2010). 
Due to initially bad model fit, we additionally relaxed the restraint on cross-loadings for the 
two-, four- and ten- factorial solutions in order to test whether model fit would improve. We 
did so by setting sequentially less strict informative priors for cross-loadings starting with 
variances equal to 0.001, 0.01, progressing to 0.05 and 0.1 as long as model fit would no 
longer improve. Since the two remaining models contained only one factor, relaxing 
restraints on cross-loads could not be performed on those models. 
 The reliabilities of all previously proposed FCQ scales in our sample of ARMS and 
FEP patients was estimated by the nonlinear SEM reliability coefficient of Green and Yang 
(2009), which has been termed categorical omega (ωcat) by Kelley et al. (2016). Although 
Cronbach’s alpha is the most popular measure of reliability, we did not report it here because 
it rests on several assumptions that are rarely met in practice (i.e. a one-factor CFA model 
perfectly fits the item covariances, the factor loadings of each item are equal, and items are 
continuous) and thus is frequently biased (cf. Dunn et al., 2014). Categorical omega, on the 
other hand, does not require the fulfillment of any of these assumptions and therefore has 
been recommended as the best option for estimating the reliability of composites that are the 
sum of categorical item scores (Kelley and Pornprasertmanit, 2016). In line with 
recommendations of Kelley and Pornprasertmanit (2016), we also estimated the confidence 
intervals for categorical omega by using the bias-corrected-and-accelerated bootstrap. All 
reliability calculations were performed by using the ci.reliablity function in the R package 
MBESS version 4.4.0 (Kelley, 2007) 
Reliability and homogeneity of each solution were based on tetrachoric correlations between 
the items. We used Cronbach’s alpha to determine internal consistency. Homogeneity was 
determined using Revelle’s beta. Revelle’s beta is a more conservative estimate that 
represents the lower half of split-half reliabilities and therefore, is always below or equal to 
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Cronbach’s alpha. Revelle’s beta is considered to apply to a wider range of different 
conditions as it is not biased under multidimensionality (Revelle, 1979; Soutar, 2009), while 
Cronbach’s alpha relies on the underlying assumption of a common factor. 
The abilitiesy of the various FCQ measures to predict later transition to psychosis in 
ARMS patients were tested outside the structural equation modelling framework with 
univariate Cox proportional hazard models, in which the FCQ totals or factors served as the 
independent variable and time to transition to psychosis as the outcome measure. For the 
exploratory nature of this first-time examination, we did not adjust for multiple testing at this 
step. 
Missing data in FCQ items was handled using pairwise deletion in models estimated 
with WLSMV and was automatically adjusted for in Bayesian structural equation models (for 
details, see (Asparouhov and Muthén, 2010). For reliability and predictive validity analyses, 
missing data in FCQ items were singly imputed using the missForest algorithm (Stekhoven 
and Bühlmann, 2012). Although multiple imputation is less biased than single imputation, we 
opted for a single imputation approach because the fraction of missing data was relatively 
small and thus unlikely to lead to substantial bias with single imputation. Incomplete follow-up 
information was handled in predictive validity analysis by applying survival models instead of 
binary outcome models (e.g. logistic regression). Survival models have the advantage that 
they can treat patients with incomplete follow-up as censored observations (i.e. patients can 
still provide information for estimating the probability of transition up to the time they were 
followed up). 
Structural equation models were fitted with Mplus, version 7 (Muthén and Muthén, 
1998-2010). All other analyses were performed using the R environment for statistical 
computing (R Core Team, 2014; Revelle, 2016). Data and scripts of all analyses are available 





3.1. Sample characteristics 
Of the 693 patients screened during the recruitment period, 291 were identified as 
FEP and 289 as ARMS. 140 FEP and 186 ARMS patients consented to participate in the 
FePsy study, 92 FEP and 117 ARMS additionally completed at least half of the items of the 
FCQ and were therefore used for the sample of the current study. current study. A sample of 
117 ARMS and 92 FEP patients fulfilled the inclusion criteria.  
ARMS and FEP with and without sufficient FCQ data did not differ statistically with 
regard to age, sex and years of education. Missing FCQ data in the included patients was 
relatively small with the majority of items having no more than 2% missingness (see online 
supplementary material for the proportion of data present in each item and for each pairwise 
combination) 
As expected, there were significant differences between the two patient groups with 
higher mean age, more positive symptoms and a higher BPRS total score in FEP patients 
(Table 2). Twenty-four (20.5%) ARMS patients later made a transition to psychosis within the 
follow-up (Table 2). Mean follow-up time was 1.24 years (median 0.80, range 0.03-4.86) for 
patients with later transition (ARMS-T) and 2.83 years (median 2.53, range 0.05-5.00) for 
patients without transition (ARMS-NT). The attrition rate in ARMS-NT patients after 1, 2 and 3 
years was 26%, 37%, and 55%, respectively. Although incomplete follow up in ARMS-NT 
patients was mostly due to drop-outs, some patients also had incomplete follow-up because 
they were recruited less than 5 years before the recruitment period ended. 
As expected, there were significant differences between ARMS and FEP patients with 
higher mean age, more positive symptoms and a higher BPRS total score in FEP patients 
(Table 2). FEP Patients showed significantly more positive symptoms and a higher overall 
BPRS score at baseline compared to patients that made a transition to psychosis (ARMS-T 
patients). At baseline, there were no statistically significant differences in any of the 
presented measures between ARMS-T patients and those who did not transition to psychosis 
(ARMS-NT) patients, although ARMS-T patients presented more positive symptoms, higher 
BRPS total scores and higher SANS scores. 
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Table 2 about here 
 
3.2. Model evaluation 
Overall goodness of fit and multiple fit indices for the models estimated with WLSMV 
are shown in Table 3 and those estimated with Bayesian methods in Table 4. Furthermore, 
Mplus scripts and standardized parameter estimates for all estimated structural equation 
models are available in the online supplementary material. 
All tested WLSMV models provided an acceptable fit to the data according to the CFI, 
TLI, and RMSEA (Table 3). Overall, the one-factor solution (24-item short version) suggested 
by Loas et al. (2002) had the best fitting model with both CFI and TLI being >0.98, although 
the two- and four-factor models (Mass et al., 1997; Süllwold, 1991) also showed similarly 
high CFI and TLI indices of ≥0.95. The RMSEA however was best for the four-factor model 
(0.020) and worst for the short version one-factor model (0.035). Both models based on all 
98 FCQ items (Süllwold, 1991; Yon et al., 2008) as well as the two-factor model on 50 items 
(Mass et al., 1997) provided an equally good fit with similar fit indices. Depending on the fit 
index, the four-factor model (RMSEA) or the Mass et al. (1997) two-factor-model (CFI, TLI) fit 
best of all solutions with at least 50 items (Table 3). 
 
Table 3 about here 
 
 For all BSEM models, the ppp were >0.04 and fell within the range of the 95%CI for 
the difference between the observed and the replicated chi-square values, thus indicating 
adequate model fit (Table 4). In contrast to the WSLMV analyses, the Mass et al. (1995) two-
factor model provided the best fit, as its ppp of 0.394 was closest to 0.5 (Table 4), followed 
by the 24-item short version with a ppp of 0.317. Of the four ≥50-item models, the two-factor 
model showed the best fitting value with a ppp of 0.143 using cross-loadings fixed to zero. 
 For the two-factor 50-item model suggested by Mass et al. (1997), an improvement in 
model fit could be found sequentially with increasing informative priors on the variance of the 
cross-loadings between the factors (Table 4). The model with the most flexibility allowance 
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for cross-loads, i.e. 0.1, showed a ppp closest to 0.5 (ppp = 0.193). While the already best 
fitting second two-factor model improved only slightly in ppp (0.396 for the solution with the 
most relaxed cross-loads), a considerable improvement in model fit with setting informative 
priors for variances of cross-loadings at 0.1 was found in the four-factor model, whose ppp 
improved from 0.081 to 0.261, as well as for the original ten-factor model, whit a ppp 
improvement from 0.089 to 0.448 (Table 4). Comparing the two 98-item model solutions 
using increasingly relaxed non-zero cross-loadings, the original theory-based ten-factor 
model fitted better than the data-based four-, the first two-factor model and both one-factor 
models but still less well than the best fitting second two-factor solution (Table 4). 
 
Table 4 about here 
 
3.3. Internal consistency and homogeneityScale reliability 
 Point estimates and confidence intervals of the reliability coefficient omega 
categorical for all previously proposed FCQ scales in our sample of ARMS and FEP patients 
are shown in Table 5. Most scales demonstrated good (0.9 > ωcat ≥ 0.8) or excellent (1 ≥ ωcat 
≥ 0.9) reliability. The alcohol and schizophrenia specific subscales of Mass et. al (1995) were 
the only ones with a reliability below 0.8, although they were still in the acceptable range (0.8 
> ωcat ≥ 0.7).  These were also the only scales with a lower bound of the 95% confidence 
interval below 0.7. 
For most subscales, Cronbach’s alpha was 0.90 or higher, indicating excellent reliability in 
terms of an internal consistency (Table 5). The FCQ total scale also yielded excellent results 
with a Cronbach’s alpha of 0.96 in ARMS and 0.99 in FEP. Generally, Revelle’s beta yielded 
lower values. For ARMS patients acceptable values were found for only two factors (memory, 
disturbances of automated responses), while for FEP patients values were frequently still 
good or at least acceptable (Table 5). Furthermore, several factors showed inacceptable 
Revelle’s beta values of <0.50, mainly in ARMS but also rarely in FEP patients (Table 5). In 




3.4. Survival analysis (prediction of psychosis) 
Neither any one of the factors of the six tested models nor the FCQ total score was 
found to be significantly associated with a later transition to psychosis in ARMS patients 
(Table 6). 
 
Table 6 about here 
 
4. Discussion 
The present study investigated for the first time the goodness of fit of all previously 
various proposed factor structures of the FCQ,  regarding their as well as scale reliabilitiesy, 
homogeneity and psychosis-predictive validitiesy of all previously proposed FCQ scales in a . 
Advancing earlier factor analytical approaches developed for continuous data, we used CFA 
and methods appropriate for categorical items to compare the model fit of six previously 
proposed factor solutions in a sample of ARMS and FEP patients. In contrast to previous 
psychometric investigations of the FCQ, methods appropriate for categorical items were 
used. Although none of the tested factorial structures was clearly rejected, results indicated 
that the one factorial solution based on 24 items suggested by Loas et al. (2002) and the 
two-factorial solution based on 17 items by Mass et al. (1995) provided the best fit to the 
data. However, if only factorial solutions based on at least 50 items are considered, the two-
factorial solution of Mass et al.  (1997) and the four factorial solution of Süllwold (1991) 
performed best. While all tested FCQ scales had at least acceptable reliability, none of these 
scales could be demonstrated to have psychosis predictive validity. Albeit considerable 
heterogeneity in findings across methods, the results indicated that the psychometric 
properties in terms of validation of factor structure, internal consistency, i.e., reliability, and 
homogeneity of the two factor solutions based on the lowest number of items are most 
satisfactory. These are the 24-item short version of the FCQ proposed by Loas et al. (2002; 
WLSMV) and the second two-factor solution found by Mass et al.  that both resulted from 
samples with exclusively and predominately schizophrenia patients.  
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The one factorial solution based on 24 items of the single factor by Loas et al. (2002), 
which provided the best fit to our data when using WLSMV estimation, were was originally 
derived by performing a PCA in a sample of schizophrenia patients. Although both parallel 
analysis and the scree test indicated that the optimal number of factors was two, the authors 
opted for a one factorial solution based on the finding that all items had their strongest 
loading on the first factor in the unrotated solution. The one-factorial solution was further 
refined by retaining only those 24 items that had a factor loading > 0.6 (Loas et al., 2002). 
The two-factor model of Mass et al. (1995) based on 17 items, which provided the best fit to 
our data when using Bayesian estimation, was not based on factor analysis but on item-by-
item comparisons of the sensitivity to either schizophrenia or alcohol dependency, revealing 
two factors construed as schizophrenia- and alcohol dependency-specific factors. However, 
the superior fit of the models suggested by Loas et al. (2002) and Mass et al. (1995) might 
be explained by the restricted number of items they are based on. To answer the question of 
how many dimensions are measured by the FCQ, fit indices of models based on a more 
complete set of items are likely more meaningful. Considering only these models, we found 
that the two and four factorial solutions of Mass et al. (1997) and Süllwold (1991), 
respectively, provided the best fit. Overall, both models were approximately equally well 
fitting. Specifically, while the two factor model had a slightly better CFI, TLI and WRMR with 
WLSMV estimation and a slightly better ppp with Bayesian estimation, the four factorial 
model had a slightly better RMSEA with WLSMV estimation. 
Thus, Oour structural results in a sample of ARMS and FEP patients suggest that BS as 
measured by the FCQ are all indicators of only one or at most twotwo to four underlying 
dimensions indicative of a general vulnerability for disturbances of mental and central-
vegetative processes, which is in line with some of the previous research on the factor 
structure of the FCQ  (Mass et al., 1997; Süllwold, 1991), as well reported results from 
parallel analyses (Loas et al., 2002; Yon et al., 2008). Contrary to this, dimensional analyses 
of interview-assessed BS (which also excluded central-vegetative complaints) had revealed 
six clear and replicable dimensions in adult prodromal and manifest psychosis samples 
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(Schultze-Lutter, 2008b; Schultze-Lutter et al., 2012b), of different specificity for psychosis. 
This difference between the dimensional structures of self- and interviewer-rated BS is most 
likely due to the lack of content validity of self-assessed BS when compared to interview-
assessed BS (Michel et al., 2016a). Also, potential effects of excluded central-vegetative 
complaints have not been studied so far. Furthermore, while items of the interview 
assessments refer to clearly distinct phenomena, items of the FCQ are less markedly 
defined, and frequently several items relate to the same interview-assessed BS (Michel et 
al., 2016b). Consequently, the 98 items of the FCQ do not cover all BS described in the 
BSABS. Moreover, they do not cover four basic symptoms and some acoustic and visual 
perception disturbances of COPER/COGDIS. These differences in item pools might have 
additionally affected dimensional analyses. 
In the present study, the reliabilities of the FCQ scales were estimated for the first time 
with a new SEM based reliability coefficient, the so called categorical omega (Green and 
Yang, 2009; Kelley and Pornprasertmanit, 2016). Unlike Cronbach’s alpha, which has been 
used in all previous psychometric investigations of the FCQ, categorical omega does not rest 
on the unrealistic assumption of a perfectly fitting unidimensional CFA model with equal 
factor loadings (i.e., essential tau-equivalence) (Kelley and Pornprasertmanit, 2016). Our 
results confirm that the FCQ total scales of both the original 98 item (Süllwold, 1991) and 
shortened 24 item versions (Loas et al., 2002) have excellent reliabilities (i.e. 0.99 and 0.95, 
respectively). Previously reported alpha values for these scales ranged between 0.95 and 
0.97 (Loas et al., 2002; Süllwold, 1991; Yon et al., 2008) and between 0.87 and 0.94 (Loas et 
al., 2002; Yon et al., 2008), respectively. Hence, our reliability estimates tended to be slightly 
higher than in previous studies, which might be explained by the fact that our method was 
not biased downwards under violation of essential tau-equivalence. The reliabilities of FCQ 
subscales, to our knowledge, have not been investigated in previous studies. We could 
therefore demonstrate for the first time that these scales have mostly good to excellent 
reliabilities. The only scales with a reliability < 0.8 were the alcohol and schizophrenia 
specific subscales of Mass et al. (1995). One possible explanation is that these scales were 
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not based on factor analytic results or similarity of item content, but on the diagnostic power 
of single items. 
Our reliability analyses provided less heterogeneous results and generally confirmed 
studies on the FCQ reporting excellent to acceptable values for Cronbach’s alpha (0.78 by 
Loas et al., 2002; Schultze-Lutter et al., 2015; 0.97 by Süllwold, 1991; 0.95 by Yon et al., 
2008) As Cronbach’s alpha might not be accurate if the assumption of unidimensionality is 
violated, Revelle’s beta provides a more accurate evaluation of homogeneity. Supporting a 
two- rather than one-dimensional structure of the FCQ, lower Revelle’s beta values still 
indicated good homogeneity of the majority of FCQ-factors in FEP patients but not in ARMS 
patients. This group difference, however, was most likely conveyed by the differences of 
homogeneity of samples that, from a diagnostic point of view, was high in the schizophrenia-
spectrum FEP patients and low in the ARMS patients that ultimately will belong to several 
diagnostic groups with different response patterns in the FCQ (Mass et al., 1995). As the 
number of ARMS-T patients was very small, we were not able to run separate analyses for 
ARMS-T and ARMS-NT. Expecting higher homogeneity in an ARMS-T compared to an 
ARMS-NT sample or in a combined sample of ARMS-T and FEP, such analyses will be 
subject of future studies of altogether larger sample size. 
In line with early studies questioning the psychosis-specificity of the FCQ (Mass et al., 
1995), we found no predictive validity with respect to later transition to psychosis in ARMS 
patients – neither for the FCQ total score nor for any of its subscales. So far, no other self-
assessments instruments for BS were tested for predictive validity. This is in contrast to 
previous studies, in which BS were assessed using semi-structured interviews such as the 
SPI-A (Schultze-Lutter et al., 2007), that reported a psychosis-predictive value of a subgroup 
of BS included in COPER and COGDIS of at least comparable quality to UHR criteria 
(Schultze-Lutter et al., 2014; Schultze-Lutter et al., 2015). This indicates that BS are only 
predictive of later transition to psychosis if descriptions of patient’s experiences are rated 
based on in-depth clinical interviews by experienced clinicians and are not simply rated by 
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patients themselves based on a single exemplary statement. This interpretation is in line with 
previous studies that have generally found poor correlations and convergent validity, 
respectively, between BS measured with the FCQ and those assessed with the gold-
standard of a semi-structured interview (Mass et al., 1995; Michel et al., 2016a). However, 
due to difficulties in assigning a BSABS or SPI-equivalence to each FCQ-item and vice 
versa, these previous studies did not include all FCQ items and COPER/COGDIS items, 
respectively. This further questions the correspondence between FCQ and BSABS or its 
subsequent scales, SPI-A and SPI-CY. While FCQ-assessed BS seem to predict worse 
symptomatic outcomes in FEP patients (Prouteau et al., 2004) – likely as a measure of 
overall symptom severity, the same does not seem to be the case for transition to psychosis 
for lack of psychosis-specificity of the FCQ. In addition to differences in item content, 
differences in the item response format could also have contributed to heterogeneous results 
regarding the predictive validities of self and interview-assessed BS. Specifically, the 
dichotomous item response format of the FCQ might have precluded the assessment of BS 
symptoms of low intensity and thus have led to items with low endorsement frequencies. 
Future studies should therefore investigate whether the use of Likert scales, as implemented 
in the SPI-A, improves the predictive validities of self-rated BS. 
The predictive value of the FCQ might be further lowered by the lack of controlling for 
confounders, such as somatic illness or substance use effects, in the assessment of BS with 
the FCQ. For example, Moritz et al. (2000a) questioned the construct validity of the FCQ, as 
it found evidence that the FCQ score correlated significantly with the administered dose of 
antipsychotic medication. The authors found a significant positive correlation of BS measured 
with the FCQ with neuroleptic dosage instead of the expected opposite treatment effects, 
even when controlled for other psychopathology. While in interviews the co-occurrence of BS 
with medication or drug use is controlled for, this is not done in the FCQ. However, a 
medication effect was controlled for in our sample, because patients with a summarized 
chlorpromazine equivalent dose of 2500 mg or higher were excluded from study 
participation. Furthermore, ARMS patients were not treated with antipsychotics after baseline 
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unless after transition, while FEP patients were treated with antipsychotics only after 
completion of baseline assessments. Thus, further supported by the lack of differences in 
medication between patient groups at baseline, we do not assume that such a medication 
effect significantly biased our results. 
 A limitation of our study was the rather small sample size of just over 200 participants. 
Although Bayesian analysis has been shown to perform well even with smaller sample sizes, 
it was not possible to estimate the factor models for ARMS and FEP patients or ARMS-T and 
ARMS-NT patients separately. Hence, it was also not possible to estimate scale reliabilities 
for these groups separately. As most ARMS patients did not transition to psychosis, the two 
patient groups do not completely pertain to the same spectrum of disorders, and therefore it 
would be interesting to investigate possible factor invariance across patient groups. A study 
on BSABS dimensions did not find differences between ARMS-T and FEP patient groups but 
with a subsample of patients suffering from depressive disorders (Schultze-Lutter, 2008a). 
 
 
5. Conclusion and directions for future research 
 Depending on the method used, our results suggest a one-or at most twotwo to four-
factorial structure based on a small selection of items to best fit the CFA modelfull 98 item 
version of the FCQ. Since this is the first study to use CFA, categorical item methodology 
and a sample of early detection of psychosis patients (ARMS and FEP), more research of 
this nature is clearly needed. Studies on the factor invariance of the FCQ in separate 
samples of ARMS and FEP patients as well as ARMS-NT and ARMS-T and a combined 
sample of ARMS-T and FEP patients would be interesting. Although we could not 
demonstrate that any FCQ scales have predictive validities, it might still be useful to apply 
this questionnaire in clinical practice to assess subjectively experienced BS in ARMS 
patients and thereby to facilitate personalized treatment (e.g. initiating cognitive remediation). 
Since the FCQ as a self-report represents a more economical possibility to assess BS as 
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compared to more time- and resource-intensive semi-structured interviews, it seems 
important to develop scales of better convergent validity of items with interview-assessed BS 
to fully and broadly exploit the advantages of the BS approach in the early detection of 
psychosis. 
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Table 1 The Frankfurt Complaint Questionnaire: Factor solutions and corresponding items. 
Model Original Süllwold (1991) Mass et al. (1997) Mass et al. (1995) Loas et al. (2002) Yon et al. 
(2008) 
Number of factors / 
items 
10 / 98 4 / 98 2 / 50 2 / 18 1 / 24 1 / 98 
N  229 692 242 310 399 
Sample  Schizophrenia patients Schizophrenia patients 










Age (mean)  32.8 years 40.7 years 37.3 years 39.23 years 24.3 years 
Gender Male 











Version German German German German French Spanish 
Cronbachs’ alpha n.a. 0.96 n.a. n.a. 0.78 0.95 
Factors 1. Loss of control 
2. Simple perception* 





8. Lack of automatism 
9. Anhedonia and anxiety 
10. Sensory overstimulation 
1. Disturbances of automated 
responses* 




















1. 7, 22, 33, 74, 83, 85, 86, 96 
2. 19, 24, 25, 29, 45, 47, 50, 51, 63, 67, 
84, 92 
3. 14, 23, 26, 27, 97, 30, 76, 79, 97 
4. 31, 40, 42, 66, 69, 71, 82, 90, 93, 94 
5. 2, 4, 12, 35, 36, 39, 43, 54, 70 
6. 8, 37, 52, 60, 62, 68, 73, 78, 88, 91 
7. 5, 9, 11, 18, 20, 34, 44, 59, 64, 81 
8. 6, 13, 17, 38, 46, 48, 56, 57, 75, 77 
9. 1, 15, 16, 28, 41, 55, 72, 87, 95, 98 
10. 3, 10, 21, 32, 49, 53, 58, 61, 65, 80, 89 
1. 33, 35, 36, 42, 48, 52, 54, 60, 63, 
67, 68, 69, 70, 71, 73, 85,88, 89, 
91, 94,95, 96 
2. 3, 5, 9, 11, 14, 18, 19, 20, 21, 23, 
24, 25, 29, 30, 32, 34, 40, 45, 47, 
50, 51, 59, 64, 67, 76, 79, 81, 84, 
87, 92 
3. 1, 6, 8, 15, 16, 17, 22, 26, 27, 28, 
31, 37, 38, 39, 43, 49, 55, 57, 72, 
75, 77, 78, 82, 90, 93, 97, 98 
4. 2, 4, 7, 10, 12, 13, 44, 46, 53, 56, 
58, 61, 62, 65, 74, 80, 83, 86 
1. 1, 5-8, 17, 27, 31, 35-39, 
42, 46, 52, 54, 56, 65, 
66, 68-71, 73, 75, 77, 
78, 80, 82, 90, 93, 94, 
95, 96, 98 
2. 14, 18, 19, 23-25, 29, 
32, 45, 51, 63, 76, 79, 
84 
1. 11, 14, 15, 63, 81, 
90, 93, 94 
2. 2, 13, 16, 28, 41, 
47, 52, 56, 87 
26, 27, 35, 36, 
38, 39, 42, 44, 
45, 46, 55, 60, 
66, 69, 73, 75, 
80, 85, 86, 89, 
93, 95, 96, 98 
1-98 
Method Grouping according to phenomenological 
similarities 







VE n.a. 72% 59.6% n.a. 65.30 % 68.98% 
Note: EFA = Exploratory Factor Analysis, PCA = Principal Component Analysis, n.a. = not available, VE= variance explanation 
         *Factors and items most likely corresponding to COGDIS or COPER in bold (Michel et al., 2016a) 
 
Table 2: Sociodemographic and clinical sample characteristics 



















Age mean (SD)* 27.3 (7.99) 25.4 (7.46) 25.6 (5.99) 29.7 (8.37) <0.001 0.993 <0.001 0.051 
Gender** Women (%) 67 (32.1%) 31 (33.3%) 7 (29.2%) 29 (31.5%) 0.917 1.000 1.000 1.000 
 Men (%) 142 (67.9%) 62 (66.7%) 17 (70.8%) 63 (68.5%)     
Years of education mean (SD)* 11.5 (2.87) 11.6 (3.05) 11.4 (2.06) 11.4 (2.89) 0.882 0.931 0.897 0.997 
Occupation** Unemployed (%) 66 (35.3%) 24 (29.3%) 4 (18.2%) 38 (45.8%) 0.099 0.425 0.256 0.151 
 Employed (%) 57 (30.5%) 29 (35.4%) 6 (27.3%) 22 (26.5%)     
 In education (%) 49 (26.2%) 23 (28.0%) 9 (40.9%) 17 (20.5%)     
 Other (%) 15 (8.02%) 6 (7.32%) 3 (13.6%) 6 (7.23%)     
Years of Follow up mean (SD)*  2.83 (2.86) 1.24 (1.30)      
BPRS Positive Symptoms  
mean (SD)* 
9.57 (4.50) 6.53 (2.58) 8.13 (2.40) 13.3 (3.86) <0.001 0.083 <0.001 <0.001 
BPRS total score mean (SD)* 43.7 (12.1) 37.3 (8.33) 42.1 (8.86) 50.9 (12.4) <0.001 0.125 <0.001 0.001 
SANS total score mean (SD)* 22.9 (15.7) 22.0 (16.6) 25.8 (16.2) 23.0 (14.7) 0.597 0.568 0.919 0.732 
Note: ARMS = at-risk mental state (T = transition, NT = non-transition); FEP = first episode psychosis; BPRS = Brief Psychiatric Rating Scale; SANS = Scale 
for the Assessment of Negative Symptoms 
Continuous variables* were tested using ANOVA, categorical variables** using 
2
 test statistics or Fisher exact test in case of cell counts <5. 





















Mass et al. 
(1997) 




Mass et al. 
(1995) 




Loas et al. 
(2002) 




Yon et al. 
(2008) 




Note: WLSMV = weighted least square mean and variance adjusted estimator (2<0.05 = good fit, 
<0.08 = adequate fit, >0.08 = poor fit), CFI = Comparative Fit Index (>0.95 = good fit, >0.9 = 
adequate fit, <0.9 = poor fit), TLI = Tucker-Lewis-Index (>0.95 = good fit, >0.9 = adequate fit, <0.9 
suggests poor fit), RMSEA = Root Mean Square Error of Approximation (<0.05 = good fit, <0.08 = 
adequate fit, >0.08 = poor fit), WRMR = weighted root mean residual (<1.0 = adequate model fit), CI 




Table 4: Fit of the factor models estimated with Bayesian method 
Model Number of 
factors 
Cross-loads Number of 
parameters 







     lower limit upper limit 
Original 10 0 241 0.089 -132.090 556.490 
 0.001 1123 0.138 -152.596 528.073 
 0.01 1123 0.219 -197.821 458.485 
 0.05 1123 0.383 -294.922 383.571 
 0.1 1123 0.448 -317.942 356.685 
Süllwold (1991) 4 0 200 0.081  -94.850 566.360 
 0.001 491 0.082  -99.837 570.740 
 0.01 491 0.208 -139.130 540.545 
 0.05 491 0.200 -185.160 488.248 
 0.1 491 0.261 -223.003 450.478 
Mass et al. (1997) 2 0 101 0.143  -75.050 245.540 
 0.01 151 0.167  -80.590 243.600 
 0.05 151 0.191  -88.520 233.250 
 0.1 151 0.193  -88.860 231.240 
Mass et al. (1995) 2 0 35 0.394  -45.612  60.755 
 0.001 52 0.389  -46.699  61.196 
 0.01 52 0.396  -46.801  60.807 
 0.05 52 0.405  -47.630  60.197 
 0.1 52 0.416  -48.345  59.312 
Loas et al. (2002)* 1 / 24 items 0 48 0.317  -60.490 76.970 
Yon et al. (2008)* 1 / 98 items 0 196 0.042  -38.680 647.450 
Note: CI = confidence interval; ppp = posterior predictive p-value (ppp close to 0.5 = good model fit) 




Table 5: Scale reliabilities 
Model Scale Number of items Omega categorical 
Original Loss of control 8 0.84 [0.78; 0.87] 
Simple perception 10 0.86 [0.74; 0.90] 
Complex perception 10 0.86 [0.61; 0.90] 
Language 10 0.91 [0.85; 0.92] 
Thought 10 0.87 [0.82; 0.89] 
Memory 10 0.88 [0.82; 0.91] 
Motility 10 0.84 [0.69; 0.87] 
Loss of automatization 10 0.87 [0.82; 0.89] 
Anxiety / Anhedonia 10 0.80 [0.71; 0.83] 
Sensory 
overstimulation 
10 0.83 [0.76; 0.86] 
Süllwold (1991) Disturbances of 
automated responses 
22 0.95 [0.92; 0.95] 
Perceptual disturbances 30 0.97 [0.93; 0.97] 
Depression 27 0.96 [0.94; 0.96] 
Overinclusion 18 0.90 [0.85; 0.91] 
Mass et al. (1998) Dysphoric concomitants 
of severe illness 
particularly impairing 
concentration 
36 0.99 [0.99; 0.99] 
Subjective experiences of 
perceptual uncertainties 
14 0.90 [0.74; 0.92] 
Mass et al. (1995) Alcohol dependency 
specific subscale 
 9 0.75 [0.67; 0.80] 
 FCQ Schizophrenia 
specific subscale 
 8 0.77 [0.67; 0.82] 
Loas et al. (2002) 24 item scale 24 0.95 [0.93; 0.95] 
Yon et al. (2008) FCQ total scale 98 0.99 [0.99; 1.00] 
Note: FCQ = Frankfurt Complaint Questionnaire; ARMS = At-risk mental state; FEP = First episode 
psychosis 
 
Table 5: Scale reliabilities 
  ARMS  FEP 
Model Scale n items  alpha beta  alpha beta 
Original Loss of control 8  0.80 0.67  0.91 0.82 
 Simple perception 10  0.76 0.48  0.89 0.77 
 Complex perception 10  0.65 0.41  0.88 0.70 
 Language 10  0.84 0.68  0.93 0.84 
 Thought 10  0.84 0.58  0.92 0.79 
 Memory 10  0.86 0.72  0.90 0.72 
 Motility 10  0.70 0.29  0.90 0.81 
 Loss of automatization 10  0.86 0.68  0.89 0.35 
 Anxiety/Anhedonia 10  0.79 0.49  0.83 0.59 
 Sensory overstimulation 10  0.76 0.42  0.87 0.50 
Süllwold (1991) 
 
Disturbances of automated 
responses 
22  0.91 0.73  0.96 0.80 
 Perceptual disturbances 30  0.87 0.51  0.96 0.77 
 Depression 27  0.92 0.30  0.95 0.58 
29 
 Overinclusion 18  0.84 0.45  0.93 0.57 
Mass et al. (1997) Dysphoric concomitants of 
severe illness particularly 
impairing concentration 
36  0.95 0.65  0.97 0.83 
 Subjective experiences of 
perceptual uncertainties 
14  0.78 0.63  0.92 0.78 
Mass et al. (1995) Schizophrenia specific factor 8  0.54 0.09  0.81 0.47 
 Alcohol dependency specific 
factor 
9  0.72 0.38  0.82 0.54 
Loas et al. (2002) 24 item scale 24  0.92 0.67  0.96 0.70 
Yon et al. (2008) FCQ total score 98  0.96 0.50  0.99 0.58 
Note: FCQ = Frankfurt Complaint Questionnaire; ARMS = At-risk mental state; FEP = First episode 
psychosis; Cronbach’s alpha (>0.9 = excellent, >0.8 = good, >0.7 = acceptable, >0.6 = questionable, 





Table 6: Predictive validities of the FCQ factors 





Model Factor N=93 N=24  
Original Loss of control 2.08 (1.94) 2.17 (2.12) 0.927 
Simple perception 0.89 (1.40) 0.84 (1.18) 0.843 
Complex perception 1.00 (1.19) 0.71 (0.96) 0.290 
Language 1.73 (2.15) 2.14 (2.27) 0.564 
Thought 4.20 (2.87) 4.36 (2.99) 0.784 
 Memory 2.59 (2.63) 2.01 (1.85) 0.161 
 Motility 1.26 (1.32) 1.43 (1.67) 0.846 
 Loss of automatization 3.14 (2.67) 3.20 (2.87) 0.652 
 Anxiety/Anhedonia 3.16 (2.36) 3.57 (2.44) 0.590 
 Sensory overstimulation 2.69 (2.15) 3.08 (2.57) 0.391 
Süllwold (1991) Disturbances of automated responses 5.25 (4.78) 5.57 (4.37) 0.970 
Perceptual disturbances 3.17 (3.08) 3.07 (2.94) 0.875 
Depression 7.73 (5.93) 7.97 (6.19) 0.849 
Overinclusion 6.06 (3.91) 6.20 (4.12) 0.987 
Mass et al. (1997) Dysphoric concomitants of severe 
illness particularly impairing 
concentration 
10.1 (8.40) 10.3 (8.13) 0.841 
Subjective experiences of perceptual 
uncertainties 
1.01 (1.38) 0.79 (1.22) 0.549 
Mass et al. (1995) Schizophrenia specific factor 1.04 (1.07) 1.08 (1.41) 0.970 
 Alcohol dependency specific factor 3.45 (2.09) 3.52 (2.28) 0.904 
Loas et al. (2002) 24 item scale 6.61 (5.57) 7.04 (5.30) 0.996 
Yon et al. (2008) FCQ total score 22.7 (15.5) 23.5 (15.7) 0.941 




Index of abbreviations 
APS:   Attenuated Psychotic Symptoms 
ARMS:   At risk mental state 
ARMS-T:  At Risk Mental State – Transitioned 
ARMS-NT:  At Risk Mental State – Non Transitioned 
BSABS:  Bonn Scale for the Assessment of Basic Symptoms 
BSIP: Basler Screening Instrument for early detection of Psychosis 
BLIPS: Brief Limitted Intermittend Psychotic Symptoms 
BPRS:   Brief Psychiatric Rating Scale 
BS:   Basic symptoms 
BSEM   Bayes Structure Equation Modelling 
CFA:   Confirmatory Factor Analysis 
CFI:   Comparative Fit Index 
CI:   Confidence Interval 
COPER:  Cognitive Perceptive Basic Symptoms 
COGDIS:  Cognitive Disturbances 
FCQ:   Frankfurt Complaint Questionnaire 
FEP:   First Episode Psychosis 
FePsy: Basel Project of Early detection of Psychosis (German: Früherkennung von 
Psychosen) 
EFA: Exploratory Factor Analysis 
PCA:   Principal Component Analysis 
RMSEA:  Root Mean Square Error of Approximation 
SANS:   Scale for the Assessment of Negative Symptoms 
SPI-A / SPI-CY Schizophrenia Pronessinstrumen – Adult / Children and Youth version 
TLI:   Tucker-Lewis-Index 
UHR:   Ultra High Risk 
WLSMV:  Weighted Least Square Mean and Variance adjusted estimator 
WRMR:  Weighted Root Mean Residual 
 
